| 52442 | In this add–on procedure, the provider uses a cystourethroscope to place an additional permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 120 | $750 | $91.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 630 | $90 | $57.6K |
| 55874 | Under imaging guidance, the provider inserts a needle through the perineum, the area between the anus and the scrotum, and injects one or more biodegradable materials, i.e., material that decomposes… | 20 | $2,470 | $51.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 610 | $60 | $36.4K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 170 | $200 | $33.7K |
| 52441 | Using a cystourethroscope, the provider places a single permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 30 | $1,070 | $31.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 170 | $130 | $21.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 130 | $110 | $14.6K |
| 52224 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 20 | $650 | $13K |
| 0421T | N/A | 20 | $550 | $10.4K |